Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Arcadia Biosciences (RKDA) Income from Non-Controlling Interests (2020 - 2023)

Arcadia Biosciences' Income from Non-Controlling Interests history spans 4 years, with the latest figure at -$5000.0 for Q2 2023.

  • For Q2 2023, Income from Non-Controlling Interests rose 75.0% year-over-year to -$5000.0; the TTM value through Jun 2024 reached -$5000.0, up 94.95%, while the annual FY2023 figure was -$5000.0, 97.88% up from the prior year.
  • Income from Non-Controlling Interests reached -$5000.0 in Q2 2023 per RKDA's latest filing, up from -$84000.0 in the prior quarter.
  • In the past five years, Income from Non-Controlling Interests ranged from a high of -$5000.0 in Q2 2023 to a low of -$774000.0 in Q3 2020.
  • Average Income from Non-Controlling Interests over 4 years is -$239384.6, with a median of -$161000.0 recorded in 2021.
  • Peak YoY movement for Income from Non-Controlling Interests: plummeted 269.61% in 2021, then surged 98.49% in 2022.
  • A 4-year view of Income from Non-Controlling Interests shows it stood at -$290000.0 in 2020, then decreased by 3.79% to -$301000.0 in 2021, then surged by 72.09% to -$84000.0 in 2022, then surged by 94.05% to -$5000.0 in 2023.
  • Per Business Quant, the three most recent readings for RKDA's Income from Non-Controlling Interests are -$5000.0 (Q2 2023), -$84000.0 (Q4 2022), and -$10000.0 (Q3 2022).